Stem cell technology pioneer, DefiniGEN Ltd has joined the Pfizer-inspired European Bank for induced pluripotent stem cells (EBiSC) consortium.
Cambridge UK life science entrepreneur Dr Catherine Beech is spearheading a truly international startup initially targeting eye disease but with applications in cancer and other disease areas.
Investor interest in the Cambridge UK life science cluster is running at its highest level for more than a decade, according to serial biotechnology entrepreneur Andy Richards.
Cambridge UK Medtech business Antitope Limited and University College London are collaborating to humanise an anti-LRG1 antibody as part of an MRC-funded translational research and product development programme being undertaken by the UCL Institute of Ophthalmology.
Superchip giant ARM Holdings has fortified its ‘pay-it-forward’ strategy to help Cambridge UK technology startups by pumping an additional US$100k into healthcare fledgling SimPrints.
Seasoned Cambridge market watchers are used to seeing companies in the technology sector pivot – sometimes pirouette.
A cutting edge alliance between MedTech specialists in Cambridge UK and Canada is taking technology to eliminate harmful side effects of medicinal drugs into the Cloud.
UK technology innovator Cambridge Consultants plans to more than triple its American headcount after moving its US headquarters.
Abcam, the Cambridge UK medical technology enabler, is targeting Australasia with a new direct selling business model.
Optibrium, the Cambridge UK business that develops software for drug discovery, has unveiled new desktop technology to boost data visualisation and analysis of compound data.
Cambridge medical technology pioneer Rapid Biosensor Systems Ltd is making preparations for a UK IPO.
One of the Cambridge medical technology cluster’s brightest stars, GW Pharmaceuticals, saw its UK share price dip 11.50p (2.73 per cent) as losses widened in the three months to June 30.
UK fertility technology pioneer Cambridge Temperature Concepts has reportedly raised more than $9 million in two tranches to underpin expansion in the US and develop a next generation product.
A new machine learning technique has been developed at the Institute of Food Research (IFR) in Norwich to analyse risk patterns in cervical cancer. It could also be harnessed to detect similar development patterns in bowel and prostate cancers.
Lintbells, a manufacturer of functional nutrition products for animals, won the ‘Market Mover’ category at GrowthAccelerator’s The Brave & The Bold awards.
Vernalis, the Cambridge medical technology business, has posted a strong financial performance ahead of market expectations for the six months to June 30 – despite a dip in profit and revenues from an admittedly high base.
- Gene editing world leaders boost Horizon SAB
- Vernalis cashes in on French connection
- Cambridge steers £300m UK bid to be genomics world leader
- Cambridge MedTech designed to clean up surgical instruments
- Papworth boost to heart disease drug makers
- Eagle flying as new team takes wing
- UEA technology helps the colour blind
- Tristel cleans up with fifth profit upgrade in a year
- Horizon wins $835,000 Otsuka deal
- Animal magic as Cambridge vet telemedicine firm goes global
- Horizon scales globally as revenues soar 36 per cent
- Diagnostic targets earlier detection of Down’s syndrome
- Cough cold remedy not to be sneezed at
- Abcam outguns profit targets
- Cambridge breast cancer detector targets Oz
- Brain health business builds growth platform
Page 1 of 62